Archives

CONCLUSION: The superoxide dismutase does not seem to change with thyroid cancer and thyroidectomy but both antioxidant glutathione peroxidase and lipid peroxidation product malondialdehyde do. These preliminary findings may point out oxidant/antioxidant imbalance associated with thyroid cancer.
PMID: 19030755 [PubMed - in process] (Source: Acta Cirurgica Brasileira)

CONCLUSIONS: Unilateral TAO is not different and just as severe as bilateral TAO. At initial work-up MRI shows signs of bi-laterality in 45% (4/9), with mild involvement of 1 or 2 extra-ocular muscles. The radiological status of affected muscles does not normalize, even in the very long term.
PMID: 19013383 [PubMed - in process] (Source: European Journal of Internal Medicine)

Conclusion: Although surgery continues to be commonly recommended, strategies for such patients should increasingly seek to define treatment based on the estimation of an individual's thyroid cancer risk in comparison with associated operative risk and morbidity. In doing so, the rate of unnecessary surgical procedures and associated complications can be reduced.
PMID: 18987277 [PubMed - in process] (Source: The Journal of Clinical Endocrinology and Metabolism)

CONCLUSIONS: In this study, PMC was found in 49.9 percent of patients, which, to our knowledge, is higher than any other reported incidence. A threshold of >/=4 mm was more significant than 5 mm for carrying increased risk for extrathyroidal spread. There was no significant difference in PMC incidence in patients with malignant vs benign disease.
PMID: 18984270 [PubMed - in process] (Source: Otolaryngology - Head and Neck Surgery)

CONCLUSIONS: Based upon our clinicopathologic findings and review of the literature, we conclude that thyroidectomies in at-risk patients are very frequently associated with C-cell hyperplasia and/or MMC; however, the clinical prognosis for these patients is very good.
PMID: 18976013 [PubMed - in process] (Source: Archives of Pathology and Laboratory Medicine) MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.